Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2008
07/30/2008EP1737462B1 Pyrimidines with tie2 (tek) activity
07/30/2008EP1685113B1 Substituted pyrazoles as ppar agonists
07/30/2008EP1660447B1 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
07/30/2008EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
07/30/2008EP1606267B1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
07/30/2008EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors
07/30/2008EP1542973B1 2,4-substituted indoles and their use as 5-ht6 modulators
07/30/2008CN101233132A Compounds for modulating TRPV3 function
07/30/2008CN101233115A Indole and benzimidazole derivatives
07/30/2008CN101233112A Benzoquinazoline derivatives and their use in treating bone disorders
07/30/2008CN101233108A Cyclic amine derivative having substituted alkyl group
07/30/2008CN101232884A Quinoline derivatives as antibacterial agents
07/30/2008CN101231243A Agent and method for testing reticulocyte
07/30/2008CN101230067A Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
07/30/2008CN101230057A Method for the synthesis of a benzimidazole compound
07/30/2008CN101230038A Pyridine carboxamide derivatives and their use as pesticides
07/30/2008CN101230034A Nitrogen hetero-cycle compounds for use in the treatment of 5-hydroxide tryptamines related diseases
07/30/2008CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
07/30/2008CN101229165A Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
07/30/2008CN100406454C Pyrazole compounds useful as protein kinase inhibitors.
07/30/2008CN100406453C 4-anilino-quinazoline derivatives as antiproliferative agents
07/30/2008CN100406452C N-phenyl-2-pyrimidine-amine derivatives
07/30/2008CN100406442C 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
07/30/2008CN100406441C Cyclic amine compounds
07/30/2008CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors
07/29/2008US7405310 Non-nucleoside reverse transcriptase inhibitors
07/29/2008US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors
07/29/2008US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders
07/29/2008US7405299 Compounds as pharmaceutical agents
07/29/2008US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy
07/29/2008US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
07/29/2008US7405228 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites
07/29/2008US7405221 2-(4-fluorobenzyloxy)-4-(2,4-dichlorophenyl)-5-(4-chlorophenyl)pyrimidine; antagonists or inverse agonists of the Cannabinoid-1 (CB1) receptor; antidepressant, neuroleptic, anxiolytic, antiinflammatory agent, cognition activator; psychosis, epilepsy, Parkinson's disease, and schizophrenia
07/29/2008US7405209 Protease inhibitors
07/29/2008CA2432222C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2432132C Pyrazole compounds useful as protein kinase inhibitors
07/29/2008CA2417369C Pyrazol derivatives, pest control agent comprising the same as active ingredient, and process for producing the same
07/29/2008CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
07/29/2008CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
07/29/2008CA2387762C Process of making substituted pyrazoles
07/29/2008CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions
07/29/2008CA2362217C Process for preparing phenylpyrazole pesticidal intermediates
07/29/2008CA2333008C New heterocyclically substituted amides, their production and their use
07/29/2008CA2256022C 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
07/29/2008CA2222936C Pesticidal sulfur compounds
07/29/2008CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/29/2008CA2214086C Pyrazole derivatives and processes for the preparation thereof
07/29/2008CA2175767C Adhesion receptor antagonists
07/25/2008CA2617463A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents
07/24/2008WO2008089201A2 Heterocyclic-substituted piperidine as orl-1 ligands
07/24/2008WO2008089015A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
07/24/2008WO2008089005A2 Renin inhibitors
07/24/2008WO2008088937A1 Quinolynylmethylimidizoles as therapeutic agents
07/24/2008WO2008088936A1 Quinolynylmethylimidizoles as therapeutic agents
07/24/2008WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
07/24/2008WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β
07/24/2008WO2008087665A2 Process for preparation of lansoprazole
07/24/2008WO2008087529A1 Nicotinic acetylcholine receptor modulators
07/24/2008WO2008087278A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
07/24/2008WO2008087081A1 Process for solvent removal from omeprazole salts
07/24/2008WO2008068272A3 Antibacterial quinoline derivatives
07/24/2008WO2008065626A3 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors
07/24/2008WO2008065068A3 Substituted dihydroimidazoles and their use in the treatment of tumors
07/24/2008WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof
07/24/2008WO2008059370A3 Substituted bicyclocarboxyamide compounds
07/24/2008WO2008057300A9 Trpvi antagonists and uses thereof
07/24/2008WO2008053352A3 Phenylpropionamide compounds and the use thereof
07/24/2008WO2008051406A3 Substituted imidazoles as bombesin receptor subtype-3 modulators
07/24/2008WO2008049047A3 Quinoline compounds
07/24/2008WO2008029217A3 Dipeptidyl peptidase iv inhibitors
07/24/2008WO2008026658A8 N-pyridylpiperidine compound, method for producing the same, and pest control agent
07/24/2008WO2008024497A3 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
07/24/2008WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation
07/24/2008WO2008005457A3 Pyridinonyl pdk1 inhibitors
07/24/2008WO2007121466A3 Process for preparing rimonabant
07/24/2008WO2007120638A3 Methods and compositions for modulating glycosylation
07/24/2008WO2007080401A8 Triazoloanilinopyrimidine derivatives for use as antiviral agents
07/24/2008US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors
07/24/2008US20080177077 Halogenation of methyl 3-(4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate or derivative; reacting with benzyl halide in solvent and base; chemical intermediates of 4-hydroxy-6-methylpyranone and methyl-3-amino-4-methyl benzoate; amidation, etherification, esterification; p38 kinase inhibitor
07/24/2008US20080177076 Processes for preparing substantially pure pantoprazole magnesium
07/24/2008US20080177072 3-Aminopyrazine-2-carbonylguanidine derivatives; (4-{4-[N'-(3,5-Diamino-6-chloropyrazine-2-carbonyl)guanidino]butyl}phenoxy)acetic acid 2-piperidin-1-yl-ethyl ester; hydration of mucous membranes; respiratory system and gastrointestinal disorders; skin, eye and vaginal dryness; hypotensive agents; asthma
07/24/2008US20080177070 Synthesis of piperazines, piperidines and related compounds
07/24/2008US20080177064 Dipeptidyl peptidase inhibitors
07/24/2008US20080176940 Photolabile Compounds
07/24/2008US20080176922 Uses of 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssris
07/24/2008US20080176906 excellent androgen receptor antagonism, excellent pharmacokinetics; low toxicity; anticarcinogenic agents; 1-{[6-Chloro-5-(hydroxymethyl)pyridin-3-yl]methyl}-4-(4-cyanophenyl)-2,5-dimethyl-1H-pyrrole-3-carbonitrile
07/24/2008US20080176904 Such as 1-(2,2-dimethylpropyl)-4-propyl-5-{4-[4-(1H-tetrazol-5-yl)phenoxy]butoxy}-1H-indole; neurological and psychiatric disorders
07/24/2008US20080176903 Novel Compounds with Analgesic Effect
07/24/2008US20080176901 Compounds and compositions as channel activating protease inhibitors
07/24/2008US20080176897 Substituted Quinolone Carboxylic Acids, Their Derivatives, Site of Action, And Uses Thereof
07/24/2008US20080176896 Modulators of cellular adhesion
07/24/2008US20080176883 Aminopyrrolidines as chemokine receptor antagonists
07/24/2008US20080176880 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
07/24/2008US20080176876 Substituted 2-Alkyl Quinazolinone Derivatives as Parp Inhibitors
07/24/2008US20080176865 Substituted arylpyrazoles
07/24/2008US20080176864 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy
07/24/2008US20080176860 8-[4-{4-[5-(Acetylamino-methyl)-2-oxo-oxazolidin-3-yl]-2-fluoro-phenoxymethyl}-4-(3,4,5,6-tetrahydroxy-tetrahydro-pyran-2-carbonyloxy)-piperidin-1-yl]-1-cyclopropyl-7-fluoro-9-methyl; microbioside; multi-drug resistant bacteria; bacterial topoisomerases and protein synthesis inhibitor
07/24/2008US20080176859 Heterocyclyamide-substituted imidazoles
07/24/2008US20080176850 able to inhibit various mutated RTs, including K103N, Y181C and Y188L
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability